Approaches for the cure of type 1 diabetes by cellular and gene therapy

Current Gene Therapy

Volumn 5, Issue 2, 2005, Pages 249-262

  Jun, H S ^a   Yoon, Ji Won ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

cell regeneration; cell specific autoimmunity; Adult stem cells; Embryonic stem cells; Insulin gene therapy; Islet transplantation; Type 1 diabetes

Indexed keywords

AZATHIOPRINE; BORONIC ACID DERIVATIVE; CD11B ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACLIZUMAB; ENZYME INHIBITOR; FAS LIGAND; GLUCOSE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; LYMPHOCYTE ANTIBODY; MANGANESE SUPEROXIDE DISMUTASE; MONOCLONAL ANTIBODY CD3; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL XL; RAPAMYCIN; SCATTER FACTOR; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ADOPTIVE IMMUNOTHERAPY; AUTOIMMUNITY; BODY WEIGHT DISORDER; CADAVER DONOR; CELL DESTRUCTION; CELL FUNCTION; CELL REGENERATION; CLINICAL TRIAL; DIARRHEA; EMBRYO CELL; FATIGUE; GENE THERAPY; GRAFT FAILURE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; ISOLATED PANCREAS ISLET; MALIGNANT NEOPLASTIC DISEASE; MOUTH ULCER; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; REVIEW; STEM CELL; WEIGHT REDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENE THERAPY; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; STEM CELL TRANSPLANTATION;

EID: 15944397246     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523053544209     Document Type: Review

References (192)

1. Abai, A.M., Hobart, P.M. and Barnhart, K.M. (1999) Insulin delivery with plasmid DNA. Hum. Gene Ther., 10: 2637-2649.
2. Abraham, E.J., Leech, C.A., Lin, J.C., Zulewski, H. and Habener, J.F. (2002) Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology, 143: 3152-3161.
3. Adams, A.B., Shirasugi, N., Durham, M.M., Strobert, E., Anderson, D., Rees, P., Cowan, S., Xu, H., Blinder, Y., Cheung, M., Hollenbaugh, D., Kenyon, N.S., Pearson, T.C. and Larsen, C.P. (2002) Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes, 51: 265-270.
4. Adorini, L., Gregori, S. and Harrison, L.C. (2002) Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med., 8: 31-38.
5. Alexander, A.M., Crawford, M., Bertera, S., Rudert, W.A., Takikawa, O., Robbins, P.D. and Trucco, M. (2002) Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51: 356-365.
6. Ashery-Padan, R., Zhou, X., Marquardt, T., Herrera, P., Toube, L., Berry, A. and Gruss, P. (2004) Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes. Dev. Biol., 269: 479-488.
7. Assady, S., Maor, G., Amit, M., Itskovitz-Eldor, J., Skorecki, K.L. and Tzukerman, M. (2001) Insulin production by human embryonic stem cells. Diabetes, 50: 1691-1697.
8. Atkinson, M.A. and Eisenbarth, G.S. (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 358: 221-229.
9. Bach, J.F. (1995) Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. J. Autoimmun., 8: 439-463.
10. Ballinger, W.F. and Lacy, P.E. (1972) Transplantation of intact pancreatic islets in rats. Surgery, 72: 175-186.
11. Barrou, Z., Seaquist, E.R. and Robertson, R.P. (1994) Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia. Diabetes, 43: 661-666.
12. Barshes, N.R., Lee, T., Goodpasture, S., Brunicardi, F.C., Alejandro, R., Ricordi, C., Soltes, G., Barth, M., Hamilton, D. and Goss, J.A. (2004) Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. Transplant. Proc., 36: 1127-1129.
13. Beattie, G.M., Montgomery, A.M., Lopez, A.D., Hao, E., Perez, B., Just, M.L., Lakey, J.R., Hart, M.E. and Hayek, A. (2002) A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes, 51: 3435-3439.
14. Benhamou, P.Y., Mullen, Y., Shaked, A., Bahmiller, D. and Csete, M.E. (1996) Decreased alloreactivity to human islets secreting recombinant viral interleukin 10. Transplantation, 62: 1306-1312.
15. Benhamou, P.Y., Moriscot, C., Richard, M.J., Beatrix, O., Badet, L., Pattou, F., Kerr-Conte, J., Chroboczek, J., Lemarchand, P. and Halimi, S. (1998) Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia, 41: 1093-1100.
16. Bennet, W., Sundberg, B., Lundgren, T., Tibell, A., Groth, C.G., Richards, A., White, D.J., Elgue, G., Larsson, R., Nilsson, B. and Korsgren, O. (2000) Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation, 69: 711-719.
17. Berney, T., Pileggi, A., Molano, R.D., Poggioli, R., Zahr, E., Ricordi, C. and Inverardi, L. (2003) The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Transplantation, 76: 1669-1674.
18. Blyszczuk, P., Czyz, J., Kania, G., Wagner, M., Roll, U., St-Onge, L. and Wobus, A.M. (2003) Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl. Acad. Sci. U. S. A., 100: 998-1003.
19. Bonner-Weir, S., Baxter, L.A., Schuppin, G.T. and Smith, F.E. (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42: 1715-1720.
20. Bonner-Weir, S., Taneja, M., Weir, G.C., Tatarkiewicz, K., Song, K.H., Sharma, A. and O'Neil, J.J. (2000) In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. U. S. A., 97: 7999-8004.
21. Bonner-Weir, S. and Sharma, A. (2002) Pancreatic stem cells. J. Pathol., 197: 519-526.
22. Bottino, R., Lemarchand, P., Trucco, M. and Giannoukakis, N. (2003) Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Ther., 10: 875-889.
23. Cantarovich, D., Blancho, G., Potiron, N., Jugeau, N., Fiche, M., Chagneau, C., Letessier, E., Boeffard, F., Loth, P., Karam, G., Soulillou, J.P. and Le Mauff, B. (2002) Rapid failure of pig islet transplantation in non human primates. Xenotransplantation, 9: 25-35.
24. Chatenoud, L., Thervet, E., Primo, J. and Bach, J.F. (1994) Anti-CD3 anti-body induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A., 91: 123-127.
25. Chatenoud, L. (2003) CD3-specific antibody-induced active tolerance: from bench to bedside. Nat. Rev. Immunol., 3: 123-132.
26. Chen, R., Doiron, B. and Kahn, A. (1995) Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector. FEBS Lett., 365: 223-226.
27. Chen, R., Meseck, M., McEvoy, R.C. and Woo, S.L. (2000) Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Ther., 7: 1802-1809.
28. Chen, R., Meseck, M.L. and Woo, S.L. (2001) Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Mol. Ther. 3: 584-590.
29. Cheung, A.T., Dayanandan, B., Lewis, J.T., Korbutt, G.S., Rajotte, R.V., Bryer-Ash, M., Boylan, M.O., Wolfe, M.M. and Kieffer, T.J. (2000) Glucose-dependent insulin release from genetically engineered K cells. Science, 290: 1959-1962.
30. Choi, J.B., Uchino, H., Azuma, K., Iwashita, N., Tanaka, Y., Mochizuki, H., Migita, M., Shimada, T., Kawamori, R. and Watada, H. (2003) Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia, 46: 1366-1374.
31. Cicalese, L., Giacomoni, A., Rastellini, C. and Benedetti, E. (1999) Pancreatic transplantation: a review. Int. Surg., 84: 305-312.
32. Cissell, M.A., Zhao, L., Sussel, L., Henderson, E. and Stein, R. (2003) Transcription factor occupancy of the insulin gene in vivo Evidence for direct regulation by Nkx2.2. J. Biol. Chem., 278: 751-756.
33. Corbett, J.A. (2001) K cells: a novel target for insulin gene therapy for the prevention of diabetes. Trends Endocrinol. Metab., 12: 140-142.
34. D'Ambra, R., Surana, M., Efrat, S., Starr, R.G. and Fleischer, N. (1990) Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. Endocrinology, 126: 2815-2822.
35. de Groot, M., Schuurs, T.A. and van Schilfgaarde, R. (2004) Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res., 121: 141-150.
36. de la Tour, D., Halvorsen, T., Demeterco, C., Tyrberg, B., Itkin-Ansari, P., Loy, M., Yoo, S.J., Hao, E., Bossie, S. and Levine, F. (2001) Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol. Endocrinol., 15: 476-483.
37. Deng, S., Ketchum, R.J., Yang, Z.D., Kucher, T., Weber, M., Shaked, A., Naji, A. and Brayman, K.L. (1997) IL-10 and TGF-beta gene transfer to rodent islets: effect on xenogeneic islet graft survival in naive and B-cell-deficient mice. Transplant. Proc., 29: 2207-2208.
38. Docherty, K. (2001) Growth and development of the islets of Langerhans: implications for the treatment of diabetes mellitus. Curr. Opin. Pharmacol., 1: 641-650.
39. Doiron, B., Cuif, M.H., Kahn, A. and Diaz-Guerra, M.J. (1994) Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. J. Biol. Chem., 269: 10213-10216.
40. Dong, H. and Woo, S.L. (2001) Hepatic insulin production for type 1 diabetes. Trends Endocrinol. Metab., 12: 441-446.
41. Dor, Y., Brown, J., Martinez, O.I. and Melton, D.A. (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature, 429: 41-46.
42. Easom, R.A. (2000) Beta-granule transport and exocytosis. Semin. Cell. Dev. Biol., 11: 253-266.
43. Efrat, S., Fusco-DeMane, D., Lemberg, H., al Emran, O. and Wang, X. (1995) Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. U. S. A., 92: 3576-3580.
44. Efrat, S. (2002) Cell replacement therapy for type 1 diabetes. Trends Mol. Med., 8: 334-339.
45. Efrat, S. (2004) Generation of surrogate beta cells from tissue stem cells. Curr. Diab. Rep., 4: 298-303.
46. Falqui, L. (1996) Production of mature human insulin by retrovirally engineered fibroblasts and primary rat hepatocytes. Esp. Clin. Endocrinol. Diabetes, 104: A37.
47. Falqui, L., Martinenghi, S., Severini, G.M., Corbella, P., Taglietti, M.V., Arcelloni C., Sarugeri, E., Monti, L.D., Paroni, R., Dozio, N., Pozza, G. and Bordignon, C. (1999) Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Hum. Gene Ther., 10: 1753-1762.
48. Ferber, S., Halkin, A., Cohen, H., Ber, I., Einav, Y., Goldberg, I., Barshack, I., Seijffers, R., Kopolovic, J., Kaiser, N. and Karasik, A. (2000) Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med., 6: 568-572.
49. Feutren, G., Papoz, L., Assan, R., Vialettes, B., Karsenty, G., Vexiau, P., Du Rostu, H., Rodier, M., Sirmai, J. and Lallemand, A. (1986) Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet, 2: 119-124.
50. Finegood, D.T., Scaglia, L. and Bonner-Weir, S. (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes, 44: 249-256.
51. Fleischer, N., Chen, C., Surana, M., Leiser, M., Rossetti, L., Pralong, W. and Efrat, S. (1998) Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes, 47: 1419-1425.
52. Gainer, A.L., Korbutt, G.S., Rajorte, R.V., Warnock, G.L. and Elliott, J.F. (1997) Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation, 63: 1017-1021.
53. Gainer, A.L., Suarez-Pinzon, W.L., Min, W.P., Swiston, J.R., Hancock-Friesen, C., Korbutt, G.S., Rajotte, R.V., Warnock, G.L. and Elliott, J.F. (1998) Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand. Transplantation, 66: 194-199.
54. Gallichan, W.S., Kafri, T., Krahl, T., Verma, I.M. and Sarvetnick, N. (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther., 9: 2717-2726.
55. Garcia-Ocana, A., Takane, K.K., Reddy, V.T., Lopez-Talavera, J.C., Vasavada, R.C. and Stewart, A.F. (2003) Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J. Biol. Chem., 278: 343-351.
56. Giannoukakis, N., Rudert, W.A., Ghivizzani, S.C., Gambotto, A., Ricordi, C., Trucco, M. and Robbins, P.D. (1999) Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes, 48: 1730-1736.
57. Giannoukakis, N. and Robbins, P.D. (2002) Gene and cell therapies for diabetes mellitus: strategies and clinical potential. Bio. Drugs, 16: 149-173.
58. Girman, P., Kriz, J., Dovolilova, E., Cihalova, E. and Saudek, F. (2001) The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats. Ann. Transplant., 6: 43-45.
59. Gould, G.W. and Holman, G.D. (1993) The glucose transporter family: structure, function and tissue-specific expression. Biochem. J., 295 ( Pt 2): 329-341.
60. Grey, S.T., Lock, J., Bach, F.H. and Ferran, C. (2001) Adenovirus-mediated gene transfer of A20 in murine islets inhibits Fas-induced apoptosis. Transplant. Proc., 33: 577-578.
61. Grey, ST., Longo, C., Shukri, T., Patel, V.I., Csizmadia, E., Daniel, S., Arvelo, M.B., Tchipashvili, V. and Ferran, C. (2003) Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J. Immunol., 170: 6250-6256.
62. Guo, Z., Mital, D., Mo, Y.Y., Tian, Y., Shen, J., Chong, A.S., Foster, P., Sankary, H., McChesney, L., Jensik, S.C. and Williams, J.W. (1998) Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant. Proc., 30: 589.
63. Guz, Y., Nasir, I. and Teitelman, G. (2001) Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology, 142: 4956-4968.
64. Halban, P.A., Kahn, S.E., Lernmark, A. and Rhodes, C.J. (2001) Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes, 50: 2181-2191.
65. Herold, K.C., Hagopian, W., Auger, J.A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S.E., Harlan, D.M., Xu, D., Zivin, R.A. and Bluestone, J.A. (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med., 346: 1692-1698.
66. Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray, D.A. and Bhatia, M. (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol., 21: 763-770.
67. Hohmeier, H.E., Thigpen, A., Tran, V.V., Davis, R. and Newgard, C.B. (1998) Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production. J. Clin. Invest., 101: 1811-1820.
68. Hori, Y., Rulifson, I.C., Tsai, B.C., Heit, J.J., Cahoy, J.D. and Kim, S.K. (2002) Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A., 99: 16105-16110.
69. Hughes, S.D., Johnson, J.H., Quaade, C. and Newgard, C.B. (1992) Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc. Natl. Acad. Sci. U. S. A., 89: 688-692.
70. Hughes, S.D., Quaade, C., Johnson, J.H., Ferber, S. and Newgard, C.B. (1993) Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism. J. Biol. Chem., 268: 15205-15212.
71. Hui, H., Wright, C. and Perfetti, R. (2001) Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes, 50: 785-796.
72. Huotari, M.A., Palgi, J. and Otonkoski, T. (1998) Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinology, 139: 1494-1499.
73. Hussain, M.A. and Theise, N.D. (2004) Stem-cell therapy for diabetes mellitus. Lancet, 364: 203-205.
74. Hutchings, P., Rosen, H., O'Reilly, L., Simpson, E., Gordon, S. and Cooke, A. (1990) Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature, 348: 639-642.
75. Hutton, J.C. (1994) Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases. Diabetologia, 37 Suppl 2: S48-56.
76. Ianus, A., Holz, G.G., Theise, N.D. and Hussain, M.A. (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest., 111: 843-850.
77. Iwata, H., Ogawa, N. Tkagi, T. and Mizoguchi, J. (1994) Preparation of insulin-releasing Chinese hamster ovary cell transfection of human insulin gene: its implantation into diabetic mice. In: Polymers of Biological and Biomedical Significance, Eds. Shalaby, S.W., Ikada, Y., Langer, R. & Williams, J. Oxford University Press, New York, pp306-313.
78. Iynedjian, P.B. (1993) Mammalian glucokinase and its gene. Biochem. J., 293 ( Pt 1): 1-13.
79. Jahr, H. and Bretzel, R.G. (2003) Insulin-positive cells in vitro generated from rat bone marrow stromal cells. Transplant. Proc.,, 35: 2140-2141.
80. Jin, Y.Z. and Xie, S.S. (2003) Bicistronic adenovirus-mediated gene transfer of CTLA4Ig gene and CD40Ig gene result in indefinite survival of islet xenograft. Transplant. Proc., 35: 3165-3166.
81. Jun, H., Bae, H.Y., Lee, B.R., Koll, K.S., Kim, Y.S., Lee, K.W., Kim, H. and Yoon, J. (1999) Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM) - genetic predisposition and metabolic abnormalities. Adv. Drug Deliv. Rev., 35: 157-177.
82. Kahan, B.W., Jacobson, L.M., Hullett, D.A., Ochoada, J.M., Oberley, T.D., Lang, K.M. and Odorico, J.S. (2003) Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes, 52: 2016-2024.
83. Kawai, T., Sogawa, H., Koulmanda, M., Smith, R.N., O'Neil, J.J., Wee, S.L., Boskovic, S., Sykes, M., Colvin, R.B., Sachs, D.H., Auchincloss, H., Jr., Cosimi, A.B. and DS, C.K. (2001) Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor. Transplantation, 72: 351-354.
84. Kemp, C.B., Knight, M.J., Scharp, D.W., Lacy, P.E. and Ballinger, W.F. (1973) Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature, 244: 447.
85. Kenyon, N.S., Chatzipetrou, M., Masetti, M., Ranuncoli, A., Oliveira, M., Wagner, J.L., Kirk, A.D., Harlan, D.M., Burkly, L.C. and Ricordi, C. (1999) Long-term survival and function of intrahepatic islet allografts; in rhesus monkeys treated with humanized anti-CD154. Proc. Natl. Acad. Sci. U. S. A., 96: 8132-8137.
86. Kenyon, N.S., Harlan, D.M., Alejando, R., Ricordi, C. and Minps, D.H. (2000) Islet cell transplantation. In: Diabetes Mellitus: A Fundamental and Clinical Text, 2nd edition, Eds. LeRoith, D., Taylor, S.I. & Olefsky, J.M. Williams & Wilkins, Philadelphia, pp. 507-517.
87. Kim, D., Gu, Y., Ishii, M., Fujimiya, M., Qi, M., Nakamura, N., Yoshikawa, T., Sumi, S. and Inoue, K. (2003) In vivo functioning and transplantable mature pancreatic islet-like cell clusters differentiated from embryonic stem cell. Pancreas, 27: e34-41.
88. Kishimoto, K., Dong, V.M., Issazadeh, S., Fedoseyeva, E.V., Waaga, A.M., Yamada, A., Sho, M., Benichou, G., Auchincloss, H., Jr., Grusby, M.J., Khoury, S.J. and Sayegh, M.H. (2000) The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J. Clin. Invest., 106: 63-72.
89. Kodama, S., Kuhtreiber, W., Fujimura, S., Dale, E.A. and Faustman, D.L. (2003) Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science, 302: 1223-1227.
90. Kojima, H., Nakamura, T., Fujita, Y., Kishi, A., Fujimiya, M., Yamada, S., Kudo, M., Nishio, Y., Maegawa, H., Haneda, M., Yasuda, H., Kojima, I., Seno, M., Wong, N.C., Kikkawa, R. and Kashiwagi, A. (2002) Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes, 51: 1398-1408.
91. Kojima, H., Fujimiya, M., Matsumura, K., Younan, P., Imaeda, H., Maeda, M. and Chan, L. (2003) NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med., 9: 596-603.
92. Korbutt, G.S., Elliott, J.F., Ao, Z., Smith, D.K., Warnock, G.L. and Rajotte, R.V. (1996) Large scale isolation, growth, and function of porcine neonatal islet cells. J. Clin. Invest., 97: 2119-2129.
93. Korsgren, O., Buhler, L.H. and Groth, C.G. (2003) Toward clinical trials of islet xenotransplantation. Xenotransplantation, 10: 289-292.
94. Laub, O. and Rutter, W.J. (1983) Expression of the human insulin gene and cDNA in a heterologous mammalian system. J. Biol. Chem., 258: 6043-6050.
95. Laumonier, T., Potiron, N., Boeffard, F., Chagneau, C., Brouard, S., Guillot, C., Soulillou, J.P., Anegon, I. and Le Mauff, B. (2003) CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression. Hum. Gene Ther., 14: 561-575.
96. Lechner, A., Yang, Y.G., Blacken, R.A., Wang, L., Nolan, A.L. and Habener, J.F. (2004) No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes, 53: 616-623.
97. Lee, H.C., Kim, S.J., Kim, K.S., Shin, H.C. and Yoon, J.W. (2000) Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature, 408: 483-488.
98. Lenschow, D.J., Zeng, Y., Thistlethwaite, J.R., Montag, A., Brady, W., Gibson, M.G., Linsley, P.S. and Bluestone, JA. (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science, 257: 789-792.
99. LeRoith, D. (2002) Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am. J. Med., 113 Suppl 6A: 3S-11S.
100. Levine, F. and Leibowitz, G. (1999) Towards gene therapy of diabetes mellitus. Mol. Med. Today, 5: 165-171.
101. Li, H., Colson, Y.L. and Ildstad, S.T. (1995) Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation, 60: 523-529.
102. Li, H., Inverardi, L., Molano, R.D., Pileggi, A. and Ricordi, C. (2003) Non-lethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. Transplantation, 75: 966-970.
103. Li, L., Seno, M., Yamada, H. and Kojima, I. (2001) Promotion of beta-cell regeneration by betacellulin in ninety percent-pancreatectomized rats. Endocrinology, 142: 5379-5385.
104. Li, L., Yi, Z., Seno, M. and Kojima, I. (2004) Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes, 53: 608-615.
105. Lipes, M.A., Cooper, E.M., Skelly, R., Rhodes, C.J., Boschetti, E., Weir, G.C. and Davalli, A.M. (1996) Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc. Natl. Acad. Sci. U. S. A., 93: 8595-8600.
106. Lipes, M.A., Davalli, A.M. and Cooper, E.M. (1997) Genetic engineering of insulin expression in nonislet cells: implications for beta-cell replacement therapy for insulin-dependent diabetes mellitus. Acta Diabetol., 34: 2-5.
107. Liu, Y., Rabinovitch, A., Suarez-Pinzon, W., Muhkerjee, B., Brownlee, M., Edelstein, D. and Federoff, H.J. (1996) Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Hum. Gene Ther., 7: 1719-1726.
108. Lomedico, P.T. (1982) Use of recombinant DNA technology to program eukaryotic cells to synthesize rat proinsulin: a rapid expression assay for cloned genes. Proc. Natl. Acad. Sci. U. S. A., 79: 5798-5802.
109. Lu, D., Tamemoto, H., Shibata, H., Saito, I. and Takeuchi, T. (1998) Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Ther., 5: 888-895.
110. Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R. and McKay, R. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292: 1389-1394.
111. Luzi, L. (1998) Pancreas transplantation and diabetic complications. N. Engl. J. Med., 339: 115-117.
112. Machen, J., Bertera, S., Chang, Y., Bottino, R., Balamurugan, A.N., Robbins, P.D., Trucco, M. and Giannoukakis, N. (2004) Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy. Gene Ther., 11: 1506-1514.
113. Makhlouf, L., Grey, S.T., Dong, V., Csizmadia, E., Arvelo, M.B., Auchincloss, H., Jr., Ferran, C. and Sayegh, M.H. (2004) Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation, 77: 990-997.
114. Martin, U., Kiessig, V., Blusch, J.H., Haverich, A., von der Heim, K., Herden, T. and Steinhoff, G. (1998) Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet, 352: 692-694.
115. Martinenghi, S., Cusella De Angelis, G., Biressi, S., Amadio, S., Bifari, F., Roncarolo, M.G., Bordignon, C. and Falqui, L. (2002) Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle. Gene Ther., 9: 1429-1437.
116. Mashima, H., Ohnishi, H., Wakabayashi, K., Mine, T., Miyagawa, J., Hanafusa, T., Seno, M., Yamada, H. and Kojima, I. (1996a) Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. 97: 1647-1654.
117. Mashima, H., Shibata, H., Mine, T. and Kojima, I. (1996b) Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology, 137: 3969-3976.
118. McKinnon, C.M. and Docherty, K. (2001) Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia, 44: 1203-1214.
119. Milo-Landesman, D., Surana, M., Berkovich, I., Compagni, A., Christofori, G., Fleischer, N. and Efrat, S. (2001) Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory system. Cell Transplant., 10: 645-650.
120. Miyazaki, S., Yamato, E. and Miyazaki, J. (2004) Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes, 53: 1030-1037.
121. Molano, R.D., Berney, T., Li, H., Cattan, P., Pileggi, A., Vizzardelli, C., Kenyon, N.S., Ricordi, C., Burkly, L.C. and Inverardi, L. (2001) Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Diabetes, 50: 270-276.
122. Moore, H.P., Walker, M.D., Lee, F. and Kelly, R.B. (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell, 35: 531-538.
123. Moriyama, H., Yokono, K., Amano, K., Nagata, M., Hasegawa, Y., Okamoto, N., Tsukamoto, K., Miki, M., Yoneda, R., Yagi, N., Tommaga, Y., Kikutani, H., Hioki, K., Okumura, K., Yagita, H. and Kasuga, M. (1996) Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J. Immunol., 157: 3737-3743.
124. Mottram, P.L., Murray-Segal, L.J., Han, W., Maguire, J. and Stein-Oakley, A.N. (2002) Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies. Transpl. Immunol., 10: 63-72.
125. Nicolls, M.R., Coulombe, M., Beilke, J., Gelhaus, H.C. and Gill, R.G. (2002) CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J. Immunol., 169: 4831-4839.
126. Notkins, A.L. (2002) Immunologic and genetic factors in type 1 diabetes. J. Biol. Chem., 277: 43545-43548.
127. Okitsu, T., Kobayashi, N., Jun, H.S., Shin, S., Kim, S.J., Han, J., Kwon, H., Sakaguchi, M., Totsugawa, T., Kohara, M., Westerman, K.A., Tanaka, N., Leboulch, P. and Yoon, J.W. (2004) Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes, 53: 105-112.
128. Olson, D.E., Paveglio, S.A., Huey, P.U., Porter, M.H. and Thule, P.M. (2003) Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats. Hum. Gene Ther., 14: 1401-1413.
129. Omer, A., Duvivier-Kali, V.F., Trivedi, N., Wilmot, K., Bonner-Weir, S. and Weir, G.C. (2003) Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes, 52: 69-75.
130. Phelps, C.J., Koike, C., Vaught, T.D., Boone, J., Wells, K.D., Chen, S.H., Ball, S., Specht, S.M., Polejaeva, I.A., Monahan, J.A., Jobst, P.M., Sharma, S.B., Lamborn, A.E., Garst, A.S., Moore, M., Demetris, A.J., Rudert, W.A., Bottino, R., Bertera, S., Trucco, M., Starzi, T.E., Dai, Y. and Ayares, D.L. (2003) Production of alpha 1,3-galactosyltransferase-deficient pigs. Science, 299: 411-414.
131. Rabinovitch, A., Suarez-Pinzen, W., Strynadka, K., Ju, Q., Edelstein, D., Brownlee, M., Korbutt, G.S. and Rajotte, R.V. (1999) Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes, 48: 1223-1229.
132. Rafaeloff, R., Pittenger, G.L., Barlow, S.W., Qin, X.F., Yan, B., Rosenberg, L., Duguid, W.P. and Vinik, A.I. (1997) Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J. Clin. Invest., 99: 2100-2109.
133. Rajagopal, J., Anderson, W.J., Kume, S., Martinez, O.I. and Melton, D.A. (2003) Insulin staining of ES cell progeny from insulin uptake. Science, 299: 363.
134. Ramiya, V.K., Maraist, M., Arfors, K.E., Schatz, D.A., Peck, A.B. and Cornelius, J.G. (2000) Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med., 6: 278-282.
135. Rehman, K.K., Bertera, S., Bottino, R., Balamurugan, A.N., Mai, J.C., Mi, Z., Trucco, M. and Robbins, P D. (2003) Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J. Biol. Chem., 278: 9862-9868.
136. Ricordi, C. (2003) Islet transplantation: a brave new world. Diabetes, 52: 1595-1603.
137. Ricordi, C. and Strom, T.B. (2004) Clinical islet transplantation: advances and immunological challenges. Nat. Rev. Immunol., 4: 259-268.
138. Rivera, V.M., Wang, X., Wardwell, S., Courage, N.L., Volchuk, A., Keenan, T., Holt, D.A., Gilman, M., Orci, L., Cerasoli, F., Jr., Rothman, J.E. and Clackson, T. (2000) Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287: 826-830.
139. Robertson, R.P., Kendall, D., Teuscher, A. and Sutherland, D. (1994) Long-term metabolic control with pancreatic transplantation. Transplant. Proc., 26: 386-387.
140. Robertson, R.P., Holohan, T.V. and Genuth, S. (1998) Therapeutic controversy: Pancreas transplantation for type I diabetes. J. Clin. Endocrinol. Metab., 83: 1868-1874.
141. Robertson, R.P., Davis, C., Larsen, J., Stratta, R. and Sutherland, D.E. (2000) Pancreas and islet transplantation for patients with diabetes. Diabetes Care, 23: 112-116.
142. Robertson, R.P. (2004) Islet transplantation as a treatment for diabetes - a work in progress. N. Engl. J. Med., 350: 694-705.
143. Rossini, A.A., Parker, D.C., Phillips, N.E., Durie, F.H., Noelle, R.J., Mordes, J.P. and Greiner, D.L. (1996) Induction of immunological tolerance to islet allografts. Cell Transplant., 5: 49-52.
144. Ryan, E.A., Lakey, J.R., Paty, B.W., Imes, S., Korbutt, G.S., Kneteman, N.M., Bigam, D., Rajotte, R.V. and Shapiro, A.M. (2002) Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes, 51: 2148-2157.
145. Ryan, E.A., Paty, B.W., Senior, P.A. and Shapiro, A.M. (2004) Risks and side effects of islet transplantation. Curr. Diab. Rep., 4: 304-309.
146. Ryu, S., Kodama, S., Ryu, K., Schoenfeld, D.A. and Faustman, D.L. (2001) Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J. Clin. Invest., 108: 63-72.
147. Sander, M., Sussel, L., Conners, J., Scheel, D., Kalamaras, J., Dela Cruz, F., Schwitzgebel, V., Hayes-Jordan, A. and German, M. (2000) Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development, 127: 5533-5540.
148. Sayegh, M.H. and Turka, L.A. (1998) The role of T-cell costimulatory activation pathways in transplant rejection. N. Engl. J. Med., 338: 1813-1821.
149. Scharp, D.W., Lacy, P.E., Santiago, J.V., McCullough, C.S., Weide, L.G., Falqui, L., Marchetti, P., Gingerich, R.L., Jaffe, A.S., Cryer, P.E., Anderson, C.B. and Flye, M.W. (1990) Insulin independence after islet transplantation into type I diabetic patient. Diabetes, 39: 515-518.
150. Schmidt, P., Goto, M., Wennberg, L., Groth, C.G., Le Mauff, B., Anegoll, I. and Korsgren, O. (2001) Adult porcine islets transduced with human complement regulatory proteins CD55 (DAF) or CD59 are partially protected from lysis in complement active human serum. Xenotransplantation, 8 (Suppl. 1): 3.
151. Schranz, D.B. and Lernmark, A. (1998) Immunology in diabetes: an update. Diabetes Metab. Rev., 14: 3-29.
152. Schwitzgebel, V.M., Scheel, D.W., Conners, J.R., Kalamaras, J., Lee, J.E., Anderson, D.J., Sussel, L., Johnson, J.D. and German, M.S. (2000) Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development, 127: 3533-3542.
153. Seaberg, R.M., Smukler, S.R., Kieffer, T.J., Enikolopov, G., Asghar, Z., Wheeler, M.B., Korbutt, G. and Van Der Kooy, D. (2004) Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol., 22: 1115-1124.
154. Selden, R.F., Skoskiewicz, M.J., Russell, P.S. and Goodman, H.M. (1987) Regulation of insulin-gene expression. Implications for gene therapy. N. Engl. J. Med., 317: 1067-1076.
155. Seno, M., Tada, H., Kosaka, M., Sasada, R., Igarashi, K., Shing, Y., Folkman, J., Ueda, M. and Yamada, H. (1996) Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. Growth Factors, 13: 181-191.
156. Sesti, G. (2002) Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes? Ann. Med., 34: 444-450.
157. Seung, E., Iwakoshi, N., Woda, B.A., Markees, T.G., Mordes, J.P., Rossini, A.A. and Greiner, D.L. (2000) Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood, 95: 2175-2182.
158. Shapiro, A.M., Lakey, J.R., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M. and Rajotte, R.V. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med., 343: 230-238.
159. Sharma, A., Zangen, D.H., Reitz, P., Taneja, M., Lissauer, M,E., Miller, C.P., Weir, G.C., Habener, J.F. and Bonner-Weir, S. (1999) The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes, 48: 507-513.
160. Shi, Q., Wang, D., Hadley, G.A., Bingaman, A.W., Bartlett, S.T. and Farber, D.L. (2004) Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity. Diabetes, 53: 2338-2345.
161. Shih, H.M., Liu, Z. and Towle, H.C. (1995) Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J. Biol. Chem., 270: 21991-21997.
162. Silverstein, J., Maclaren, N., Riley, W., Spillar, R., Radjenovic, D. and Johnson, S. (1988) Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N. Engl. J. Med., 319: 599-604.
163. Slack, J.M. (1995) Developmental biology of the pancreas. Development, 121: 1569-1580.
164. Soria, B., Roche, E., Berna, G., Leon-Quinto, T., Reig, J.A. and Martin, F. (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes, 49: 157-162.
165. Sosa-Pineda, B., Chowdhury, K., Torres, M., Oliver, G. and Gruss, P. (1997) The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature, 386: 399-402.
166. Stewart, C., Taylor, N.A., Green, I.C., Docherty, K. and Bailey, C.J. (1994) Insulin-releasing pituitary cells as a model for somatic cell gene therapy in diabetes mellitus. J. Endocrinol., 142: 339-343.
167. Street, C.N., Sipione, S., Helms, L., Binette, T., Rajotte, R.V., Bleackley, R.C. and Korbutt, G.S. (2004) Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes. Int. J. Biochem. Cell Biol., 36: 667-683.
168. Sussel, L., Kalamaras, J., Hartigan-O'Connor, D.J., Meneses, J.J., Pedersen, R.A., Rubenstein, J.L. and German, M.S. (1998) Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development, 125: 2213-2221.
169. Sutherland, D.E., Gruessner, R.W., Dunn, D.L., Matas, A.J., Humar, A., Kandaswamy, R., Mauer, S.M., Kennedy, W.R., Goetz, F.C., Robertson, R.P., Gruessner, A.C. and Najarian, J.S. (2001) Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann. Surg., 233: 463-501.
170. Suzuki, A., Nakauchi, H. and Taniguchi, H. (2003) Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc. Natl. Acad. Sci. U. S. A., 100: 5034-5039.
171. Teranishi, K., Alwayn, I.P., Buhler, L., Gollackner, B., Knosalla, C., Huck, J., Duthaler, R., Katopodis, A., Sachs, D.H., Schuurman, H.J., Awwad, M. and Cooper, D.K. (2003) Depletion of anti-Gal antibodies by the intravenous infusion of Gal type 2 and 6 glycoconjugates in baboons. Xenotransplantation, 10: 357-367.
172. Thule, P.M., Liu, J. and Phillips, L.S. (2000) Glucose regulated production of human insulin in rat hepatocytes. Gene Ther. 7: 205-214.
173. Thule, P.M. and Liu, J.M. (2000) Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther., 7: 1744-1752.
174. Tiedge, M., Lortz, S., Munday, R. and Lenzen, S. (1999) Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia, 42: 849-855.
175. Tourrel, C., Bailbe, D., Meile, M.J., Kergoat, M. and Portha, B. (2001) Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes, 50: 1562-1570.
176. Trivedi, N., Hollister-Lock, J., Lopez-Avalos, M.D., O'Neil, J.J., Keegan, M., Bonner-Weir, S. and Weir, G.C. (2001) Increase in beta-cell mass in transplanted porcine neonatal pancreatic cell clusters is due to proliferation of beta-cells and differentiation of duct cells. Endocrinology, 142: 2115-2122.
177. Wahren, J. and Jornvall, H. (2003) C-peptide makes a comeback. Diabetes Metab Res Rev, 19: 345-347.
178. Wanke, I.E. and Wong, N.C. (1997) Specific problems facing gene therapy for insulin-dependent diabetes mellitus: glucose-regulated insulin secretion from hepatocytes. Proc. West. Pharmacol. Soc., 40: 131-133.
179. Watanabe, T., Yonemura, Y., Yonekura, H., Suzuki, Y., Miyashita, H., Sugiyama, K., Moriizumi, S., Unno, M., Tanaka, O., Kondo, H., Bone, A.J., Takasawa, S. and Okamoto, H. (1994) Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc. Natl. Acad. Sci. U. S. A., 91: 3589-3592.
180. Winter, W.E. and Schatz, D. (2003) Prevention strategies for type 1 diabetes mellitus: current status and future directions. BioDrugs, 17: 39-64.
181. Wu, Y., Han, B., Luo, H., Shi, G. and Wu, J. (2004) Dipeptide boronic acid, a novel proteasome inhibitor, prevents islet-allograft rejection. Transplantation, 78: 360-366.
182. Yamamoto, K., Miyagawa, J., Waguri, M., Sasada, R., Igarashi, K., Li, M., Nammo, T., Moriwaki, M., Imagawa, A., Yamagata, K., Nakajima, H., Namba, M., Tochino, Y., Hanafusa, T. and Matsuzawa, Y. (2000) Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes, 49: 2021-2027.
183. Yang, L., Li, S., Hatch, H., Ahrens, K., Cornelius, J.G., Petersen, B.E. and Peck, A.B. (2002) In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. U. S. A., 99: 8078-8083.
184. Yasuda, H., Nagata, M., Arisawa, K., Yoshida, R., Fujihira, K., Okamoto, N., Moriyama, H., Miki, M., Saito, I., Hamada, H., Yokono, K. and Kasuga, M. (1998) Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J. Clin. Invest., 102: 1807-1814.
185. Yoon, J.W. and Jun, H.S. (1998) Insulin-dependent diabetes mellitus. In: Encyclopedia of Immunology, Eds. Roitt, I.M. & Delves, P.J. Academic Press, London, pp1390-1398.
186. Yoon, J.W. and Jun, H.S. (2002) Recent advances in insulin gene therapy for type 1 diabetes. Trends Mol. Med., 8: 62-68.
187. Zalzman, M., Gupta, S., Giri, R.K., Berkovich, I., Sappal, B.S., Karnieli, O., Zern, M.A., Fleischer, N. and Efrat, S. (2003) Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc. Natl. Acad. Sci. U. S. A., 100: 7253-7258.
188. Zhang, Y.C., Pileggi, A., Agarwal, A., Molano, R.D., Powers, M., Brusko, T., Wasserfall, C., Goudy, K., Zahr, E., Poggioli, R., Scott-Jorgensen, M., Campbell-Thompson, M., Crawford, J.M., Nick, H., Flotte, T., Ellis, T.M., Ricordi, C., Inverardi, L. and Atkinson, M.A. (2003) Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes, 52: 708-716.
189. Zhou, Y.P., Pena, J.C., Roe, M.W., Mittal, A., Levisetti, M., Baldwin, A.C., Pugh, W., Ostrega, D., Ahmed, N., Bindokas, V.P., Philipson, L.H., Hanahan, D., Thompson, C.B. and Polonsky, K.S. (2000) Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am. J. Physiol. Endocrinol. Metab., 278: E340-351.
190. Zimmet, P., Alberti, K.G. and Shaw, J, (2001) Global and societal implications of the diabetes epidemic. Nature, 414: 782-787.
191. Zorina, T.D., Subbotin, V.M., Bertera, S., Alexander, A.M., Haluszczak, C., Gambrell, B., Bottino, R., Styche, A.J. and Trucco, M. (2003) Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells, 21: 377-388.
192. Zulewski, H., Abraham, E.J., Gerlach, M.J., Daniel, P.B., Moritz, W., Muller, B., Vallejo, M., Thomas, M.K. and Habener, J.F. (2001) Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes, 50: 521-533.